A bipartisan group of AGs reached a $26 billion global settlement with three major drug distributors and Johnson & Johnson (“J&J”) (collectively “Companies”), pending approval by the vast majority of states and municipalities, to release the Companies from all civil liability relating to the opioid crisis.

Read More

A bipartisan group of 34 AGs, led by Minnesota AG Keith Ellison, filed an amicus brief in the U.S. Court of Appeals for the Eighth Circuit in support of North Dakota’s position in Pharmaceutical Care Management Association (“PMCA”) v. Wehbi, where North Dakota argued that states have the right to regulate pharmacy benefit managers (“PBMs”) and…

Read More

New York AG Letitia James reached a settlement with Johnson & Johnson (“J&J”) to resolve allegations that J&J’s activities relating to its manufacture and distribution of opioids caused public nuisance, amounted to common-law fraud, and violated the New York Controlled Substance Act and New York’s consumer protection and finance laws.

Read More

Mississippi AG Lynn Finch reached a settlement with Teva Pharmaceuticals USA, Inc. (“Teva”) to resolve allegations of price fixing and market allocation for numerous generic drugs in violation of the Sherman Act. The settlement stems from a 2019 complaint by 43 state AGs, and the Puerto Rico AG, against Teva and more than a dozen…

Read More

Ohio AG Dave Yost and Mississippi AG Lynn Fitch reached no-fault agreements with healthcare company Centene Corporation and its subsidiaries (collectively, “Centene”), over allegations that two of its subsidiaries—Buckeye Health Plan Community Solutions, Inc. (“Buckeye”) and Envolve Pharmacy Solutions, Inc. (“Envolve”)—overbilled the states’ Medicaid programs for pharmacy services, in violation of provider agreements with the…

Read More